Clinical Decision Making Regarding Benzodiazepine Use in PTSD
Treatment
Running Title: Clinical Decision Making
Nancy C. Bernardy PhD1, Erin Barnett
PhD2, Brian C. Lund PharmD3, Bruce
Alexander
PharmD4, Louise E. Parker PhD5,6 Aaron
Jenkyn BA7, Matthew J. Friedman MD, PhD8
1 Health Science Specialist, National Center
for PTSD, Veterans Affairs Medical Center, White River Junction, VT and
Associate Professor, Department of Psychiatry, The Geisel School of
Medicine at Dartmouth, Hanover, NH
2 Assistant Professor of Psychiatry and The
Dartmouth Institute for Health Policy and Clinical Practice, The Geisel
School of Medicine at Dartmouth, Hanover, NH
3 MS, Core Investigator, Center for
Comprehensive Access & Delivery Research and Evaluation, Iowa City
Veterans Affairs Health Care System, Iowa City, IA
4 Contract Data Manager, Center for
Comprehensive Access & Delivery Research and Evaluation, Iowa City
Veterans Affairs Health Care System, Iowa City, IA
5 University of Massachusetts Boston,
Department of Management, Boston, MA
6 VA Quality Enhancement Research Initiative
(QUERI) Program for Team-Based Behavioral Health, Department of Veterans
Affairs
7 Research Coordinator, National Center for
PTSD, Veterans Affairs Medical Center, White River Junction, VT
8 Senior Advisor, National Center for PTSD,
Veterans Affairs Medical Center, White River Junction, VT and
Departments of Psychiatry, The Geisel School of Medicine at Dartmouth,
Hanover, NH
Corresponding author and address for reprints: Dr. Nancy
Bernardy, National Center for PTSD (116D), White River Junction VA
Medical Center, 215 North Main, White River Junction, VT 05001, phone
802/296-5132, fax 802/296-5135,
Nancy.Bernardy@va.gov
Abstract count 251
Word count 4325
3 Tables